Form 4 for DNLI Denali Therapeutics Inc.
Accepted 2021-09-22 00:00:00 ET · period of report 2021-09-20 · accession 0001714899-21-000092 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-22 | 2021-09-20 | DNLI | Schuth Alexander O. | COO, Sec | M - OptEx | $0.68 | +9,045 | 95.5K | +10% | +$6,151 |
| D | 2021-09-22 | 2021-09-20 | DNLI | Schuth Alexander O. | COO, Sec | M - OptEx | $0.00 | -9,045 | 240.1K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-20 | M | A | 9,045 | $0.68 | 95,499 | D | — | — | |
| 2 | Derivative | Stock Option (right to buy) | 2021-09-20 | M | D | 9,045 | $0.00 | 240,078 | D | $0.68 · — to 2025-08-20 | 9,045 Common Stock | (F2) The vesting of the shares subject to the option is contingent upon the achievement of certain performance metrics. 50% of the shares subject to the option vested on the date the closing price of Issuer's Common Stock equaled or exceeded $40.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018; and 50% of the shares subject to the option vest on the date the closing price of Issuer's Common Stock equals or exceeds $80.00 per share on NASDAQ for 90 consecutive trading days, beginning no earlier than June 10, 2018. |